I think these are the best dividend-paying UK shares to buy now to make a passive income

I think these UK shares may offer the best means of generating a relatively high passive income today and in the long run.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Finding the best dividend-paying UK shares to buy now to obtain a worthwhile passive income can be a difficult task. After all, share prices have made gains since their March lows, yet the economic outlook is uncertain.

As such, buying high-quality businesses with generous dividend yields that can grow in the long run could be crucial in obtaining a high income return.

With that in mind, here are four FTSE 100 stocks that appear to fit the bill. They could provide a relatively high income in 2021, as well as scope for above-inflation growth in the coming years.

High-yielding UK shares

British American Tobacco and GlaxoSmithKline are among the highest-yielding UK shares at the present time. They offer generous passive incomes compared to the FTSE 100’s 3.7% yield. BAT has a yield of 7.3%, while GSK’s dividends amount to 5.7% of its share price.

BAT recently released an encouraging investor update. It showed the company is making progress in growing its non-combustible product categories, such as e-cigarettes. It’s on track to meet its long-term goal of generating £5bn in revenue from non-combustibles.

In the meantime, its plans to become more agile may allow it to deliver strong dividend growth. Its capacity to raise cigarette prices may also produce a growing dividend in the coming years.

GSK also has an improving long-term future. As well as a higher yield than other dividend-paying UK shares, its passive income prospects could gather pace as its plans to split into two separate companies are realised.

This may increase its efficiency and strengthen its financial position relative to healthcare sector peers. In the shorter term, GSK’s defensive characteristics may mean that it has a solid income outlook relative to other FTSE 100 shares.

Dividend growth opportunities for a rising passive income

SSE and Unilever offer impressive dividend growth prospects relative to other UK shares. And that could mean they offer attractive passive incomes in the long run. For example, SSE has a dividend growth plan that covers the next few years.

It expects to raise dividends by at least as much as inflation in that time. Should a loose monetary policy cause a rapidly-rising price level, this could be a major benefit to income investors. Meanwhile, its 5.7% dividend yield is two percentage points higher than that of the FTSE 100.

Unilever is forecast to grow its dividends by around 6% next year as an improving global economic outlook takes hold. Its exposure to growing consumer markets across the emerging world means it could generate impressive profit growth that makes its 3.4% dividend yield increasingly attractive.

And, with the company having a diverse range of brands and exposure to a variety of countries, its potential to deliver a reliable passive income seems to be high.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Peter Stephens owns shares of British American Tobacco, GlaxoSmithKline, SSE, and Unilever. The Motley Fool UK has recommended GlaxoSmithKline and Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »